Sales Rep “Ride Alongs” Required As Part Of Jazz’s Xyrem Settlement
Executive Summary
Jazz Pharmaceuticals' sales reps will have limited opportunities for improvisation under a corporate integrity agreement signed to settle charges of off-label detailing of Xyrem (gamma-hydroxybutyrate)
You may also be interested in...
Sleep Claim For Jazz Fibromyalgia Drug Falls On Lack Of Distinction
If Jazz's sodium oxybate is approved to treat fibromyalgia, it will go to market without a sleep claim to differentiate it from competitors
Sleep Claim For Jazz Fibromyalgia Drug Falls On Lack Of Distinction
If Jazz's sodium oxybate is approved to treat fibromyalgia, it will go to market without a sleep claim to differentiate it from competitors
Jazz Pharmaceuticals IPO Will Fund Luvox CR Commercialization
Jazz Pharmaceuticals is hoping to raise more than $100 million through its initial public offering to help fund the commercialization of its lead compound, Luvox CR (see chart: "1Jazz Pharmaceuticals IPO")